New QOTP Prescriber Type - Buprenorphine-naloxone only QOTP prescriber

New QOTP Prescriber Type - Buprenorphine-naloxone only QOTP prescriber

  • Filetype

    PDF

  • Last updated

    08 December 2020

  • Filesize

    988.52kb

Download

cart

0

As part of the Queensland Opioid Treatment Program (QOTP) Queensland Health is establishing a new buprenorphine-naloxone only prescribing option. From 7 December 2020 medical practitioners and nurse practitioners in General Practice and other community and primary health care settings will be able to apply for approval to prescribe buprenorphine-naloxone medication for the treatment of opioid dependence for up to 20 suitable patients.